GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mountain Valley MD Holdings Inc (XCNQ:MVMD) » Definitions » 3-Year RORE %

Mountain Valley MD Holdings (XCNQ:MVMD) 3-Year RORE % : -29.41% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Mountain Valley MD Holdings 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Mountain Valley MD Holdings's 3-Year RORE % for the quarter that ended in Sep. 2024 was -29.41%.

The industry rank for Mountain Valley MD Holdings's 3-Year RORE % or its related term are showing as below:

XCNQ:MVMD's 3-Year RORE % is ranked worse than
72.09% of 978 companies
in the Drug Manufacturers industry
Industry Median: -1.65 vs XCNQ:MVMD: -29.41

Mountain Valley MD Holdings 3-Year RORE % Historical Data

The historical data trend for Mountain Valley MD Holdings's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Valley MD Holdings 3-Year RORE % Chart

Mountain Valley MD Holdings Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
3-Year RORE %
- - -39.33 -9.52 -23.88

Mountain Valley MD Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.12 -41.38 -23.88 -27.12 -29.41

Competitive Comparison of Mountain Valley MD Holdings's 3-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Valley MD Holdings's 3-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's 3-Year RORE % falls into.



Mountain Valley MD Holdings 3-Year RORE % Calculation

Mountain Valley MD Holdings's 3-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.014--0.029 )/( -0.051-0 )
=0.015/-0.051
=-29.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 3-year before.


Mountain Valley MD Holdings  (XCNQ:MVMD) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Mountain Valley MD Holdings 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Mountain Valley MD Holdings's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mountain Valley MD Holdings Business Description

Traded in Other Exchanges
Address
260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm along with its subsidiaries is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats that are consumed orally.
Executives
Azhar Ali Khan Rana Senior Officer
Nancy Richardson Director
Kevin Terry Wayne Puloski Director

Mountain Valley MD Holdings Headlines

No Headlines